PAPANICOLAOU SMEARS IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE WOMEN DURING FOLLOW-UP

被引:38
作者
HEARD, I
BERGERON, C
JEANNEL, D
HENRION, R
KAZATCHKINE, MD
机构
[1] HOP COCHIN,F-75674 PARIS,FRANCE
[2] IPECA,LAB CERBA,CERGY,FRANCE
[3] INST PASTEUR,UNITE EPIDEMIOL VIRUS ONCOGENES,PARIS,FRANCE
关键词
D O I
10.1016/0029-7844(95)00282-V
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess the outcome of cervical squamous intraepithelial lesions (SIL) in human immunodeficiency virus (HIV)-seropositive women. Methods: Papanicolaou smears were followed-up prospectively in a group of 60 HIV-positive women every 6 months for 18 months. Results: The cumulative incidence of SIL at 18 months was 9% in 27 women who presented with normal Papanicolaou smears at entry. In 33 women who initially presented with SIL, the rate of persistence of cervical lesions was 95% (18 of 19) in untreated patients and 61% (eight of 13) in women who underwent surgery. In women with low-grade SIL, the persistence or progression of cervical lesions was observed in 92% of the cases (12 of 13). No invasive cancer was observed during the 18 months of the study period. Conclusion: Although the long-term outcome of SIL in this population remains unknown, our results emphasize the high rate of persistence of SIL and the relative inefficiency of conventional treatment in HIV-infected women. These findings contrast with the natural history of SIL in immunocompetent women.
引用
收藏
页码:749 / 753
页数:5
相关论文
共 21 条
[1]  
ADACHI A, 1993, OBSTET GYNECOL, V81, P372
[2]   LASER CONIZATION - THE RESULTS OF TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA [J].
ANDERSEN, ES ;
PEDERSEN, B ;
NIELSEN, K .
GYNECOLOGIC ONCOLOGY, 1994, 54 (02) :201-204
[3]   CHARACTERISTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIA IN WOMEN INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
FRUCHTER, RG ;
MAIMAN, M ;
SILLMAN, FH ;
CAMILIEN, L ;
WEBBER, CA ;
KIM, DS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (02) :531-537
[4]   RISK-FACTORS FOR SQUAMOUS INTRAEPITHELIAL LESIONS ON PAP SMEAR IN WOMEN AT RISK FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
KLEIN, RS ;
HO, GYF ;
VERMUND, SH ;
FLEMING, I ;
BURK, RD .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06) :1404-1409
[5]  
KORN AP, 1994, OBSTET GYNECOL, V83, P401
[6]   HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CERVICAL NEOPLASIA [J].
MAIMAN, M ;
FRUCHTER, RG ;
SERUR, E ;
REMY, JC ;
FEUER, G ;
BOYCE, J .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :377-382
[7]  
MAIMAN M, 1991, OBSTET GYNECOL, V78, P84
[8]  
MAIMAN M, 1993, OBSTET GYNECOL, V82, P170
[9]  
MAIMAN M, 1993, CANCER-AM CANCER SOC, V71, P402, DOI 10.1002/1097-0142(19930115)71:2<402::AID-CNCR2820710222>3.0.CO
[10]  
2-Y